Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer
Citations Over TimeTop 10% of 2014 papers
Abstract
Gastric cancer is the second leading cause of worldwide cancer mortality, yet the underlying genomic alterations remain poorly understood. Here we perform exome and transcriptome sequencing and SNP array assays to characterize 51 primary gastric tumours and 32 cell lines. Meta-analysis of exome data and previously published data sets reveals 24 significantly mutated genes in microsatellite stable (MSS) tumours and 16 in microsatellite instable (MSI) tumours. Over half the patients in our collection could potentially benefit from targeted therapies. We identify 55 splice site mutations accompanied by aberrant splicing products, in addition to mutation-independent differential isoform usage in tumours. ZAK kinase isoform TV1 is preferentially upregulated in gastric tumours and cell lines relative to normal samples. This pattern is also observed in colorectal, bladder and breast cancers. Overexpression of this particular isoform activates multiple cancer-related transcription factor reporters, while depletion of ZAK in gastric cell lines inhibits proliferation. These results reveal the spectrum of genomic and transcriptomic alterations in gastric cancer, and identify isoform-specific oncogenic properties of ZAK.
Related Papers
- → The importance of being divisible by three in alternative splicing(2005)67 cited
- → Novel isoforms of the mRNA for human female sex steroid hormone receptors(2002)29 cited
- → Characterization of a new brain‐specific isoform of the EWS oncoprotein(2001)20 cited
- → Identification and functional characterization of the novel isoforms of bovine norepinephrine transporter produced by alternative splicing(2002)7 cited
- → Characterization of the mechanisms behind the alternative splicing of the mutually exclusive exons 18N and 18A in the sodium channel gene SCN8A and mutually exclusive exons 5N and 5A in the soldium channel gene SCN9A(2011)